Guanhao Biotech Co.,Ltd. (SHE:300238)
17.17
+0.48 (2.88%)
Jan 23, 2026, 3:04 PM CST
Guanhao Biotech Revenue
Guanhao Biotech had revenue of 92.61M CNY in the quarter ending September 30, 2025, with 4.72% growth. This brings the company's revenue in the last twelve months to 392.83M, up 5.21% year-over-year. In the year 2024, Guanhao Biotech had annual revenue of 377.48M, down -6.60%.
Revenue (ttm)
392.83M
Revenue Growth
+5.21%
P/S Ratio
11.27
Revenue / Employee
741.18K
Employees
530
Market Cap
4.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 377.48M | -26.70M | -6.60% |
| Dec 31, 2023 | 404.18M | 26.89M | 7.13% |
| Jan 1, 2023 | 377.29M | -111.70M | -22.84% |
| Jan 1, 2022 | 488.98M | 52.02M | 11.91% |
| Dec 31, 2020 | 436.96M | -929.29K | -0.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao Vland Biotech INC. | 1.39B |
| Pulike Biological Engineering | 1.10B |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Innovita Biological Technology | 430.96M |
| Shanghai Shen Lian Biomedical | 292.81M |
| Shenzhen Bioeasy Biotechnology | 251.83M |
| Shanghai Hile Bio-Technology | 246.35M |